COMMUNIQUÉS West-GlobeNewswire

eTrueNorth Expands its eLabNetwork™ Platform Internationally
13/12/2017
DALLAS, Dec. 13, 2017 (GLOBE NEWSWIRE) -- e TrueNorth, the U.S.-based healthcare technology solution provider for CLIA-waived laboratories, announced today that it has grown its business internationally with a new [...]
Xbrane Biopharma informs about changes in management team
13/12/2017
Pressrelease 2017-12-13 Xbrane Biopharma AB ("Xbrane" or "the Company") announces that Carlo Colombo, Head of Production within Xbranes long acting injectable business, who forms a part of Xbranes management team, has [...]
Nephros Receives $1.8 Million in Cash from Sale of Tax Credits
13/12/2017
SOUTH ORANGE, NJ, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB: NEPH) a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid- [...]
Marinus Pharmaceuticals Added to NASDAQ Biotechnology Index
13/12/2017
RADNOR, Pa., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS ) (the “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and [...]
Strongbridge Biopharma plc Added to the NASDAQ Biotech Index
13/12/2017
DUBLIN, Ireland and TREVOSE, Pa., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP ), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
Iovance Biotherapeutics Announces Manufacturing Decision, Provides Clinical Updates and Highlights Pipeline Expansion at Analyst Day 2017
13/12/2017
- Generation 2 Manufacturing Process Selected for All Ongoing and Future TIL Clinical Development - - Company Reports Updated Results for Cohort 2 in Melanoma Study - - Two New Studies in NSCLC Patients in Collaboration [...]
Iovance Biotherapeutics Expands Pipeline of TIL Therapies into Lung Cancer
13/12/2017
Moffitt Cancer Center Phase 1 Study Combining TIL and Nivolumab Initiated in NSCLC Patients Iovance/MedImmune Clinical Collaboration to Initiate with Start of Phase 2 Study in PD-1/PDL-1 Naïve NSCLC Patients 1H 2018 SAN [...]
GW Pharmaceuticals Reacquires Full Rights to Develop and Commercialize Sativex® in U.S.
13/12/2017
LONDON, Dec. 13, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its [...]
National Research Corporation Announces Revised Class B Common Stock Recapitalization Plan
13/12/2017
All class B shares to be exchanged for one share of class A common stock plus $19.59 in cash, for total value of $53.44 per class B share Class A common stock to be sole outstanding security of the Company Previously [...]
Q Therapeutics Announces Research Collaboration With REPROCELL
13/12/2017
SALT LAKE CITY and YOKOHAMA, Japan, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Q Therapeutics, Inc., a developer of clinical-stage cell therapies for central nervous system (CNS) disease and injury, announced a collaborative [...]
Natus to Present at J.P. Morgan 36th Annual Healthcare Conference
13/12/2017
PLEASANTON, Calif., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY ) today announced that Jim Hawkins, President and Chief Executive Officer will present and Jonathan Kennedy, Executive Vice [...]
argenx announces size of proposed public offering in the United States updated to 3.5 million ADSs
13/12/2017
Regulated information - Inside information December 13, 2017 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX) a clinical-stage biotechnology company developing a deep pipeline of [...]
Photocure ASA: Presentation at the DNB Nordic Healthcare Conference, Oslo
13/12/2017
Oslo, Norway, December 13, 2017 - Photocure ASA (OSE: PHO) announces today that the company will present at the DNB Nordic Healthcare Conference on 14th of December 2017 in Oslo, Norway. Presenter will be Ambaw Bellete [...]
CORRECTION: Valerijs Maligins, Chairman of the Board of AS Olainfarm Has Passed Away - date changed
13/12/2017
Olaine, 2017-12-13 09:35 CET (GLOBE NEWSWIRE) -- Valerijs Maligins became Chairman of Olainfarm’s Board after the privatization of the company in 1997. Under his management, the company became one of the most valuable [...]
Update on C-RAD delivery of its advanced surface tracking solution to Swedish Cancer Center Nya Karolinska Solna
13/12/2017
C-RAD announced in August that a contract to supply Nya Karolinska Solna (NKS) and Södersjukhuset in Stockholm, Sweden with its latest SIGRT (Surface Image Guided Radiation Therapy) solution was signed with Elekta [...]
Nexstim Plc's Financial Information in 2018
13/12/2017
Company announcement, Helsinki, 13 December 2017, at 9 am Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or the " Company "), a medical technology company developing and marketing pioneering navigated non-invasive [...]
Sanofi : Sanofi presents R&D strategy and innovative pipeline
13/12/2017
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi presents R&D strategy and innovative pipeline · Robust pipeline expected to support long-term growth · 9 planned regulatory submissions over next 18 [...]
Sanofi : Sanofi présente sa stratégie de R&D et son portefeuille innovant
13/12/2017
Sanofi présente sa stratégie de R&D et son portefeuille innovant · Un portefeuille robuste qui devrait soutenir la croissance à long terme · Neuf soumissions réglementaires planifiées au cours des 18 prochains mois [...]
Sanofi and Regeneron announce positive topline pivotal results for PD-1 antibody cemiplimab in advanced cutaneous squamous cell carcinoma
13/12/2017
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi and Regeneron announce positive topline pivotal results for PD-1 antibody cemiplimab in advanced cutaneous squamous cell carcinoma High and durable [...]

Pages